Keywords: nearly, double, number, therapeutic, peptides, clinical, trial
Nearly double the number of therapeutic peptides in clinical trial since 1990s
Article | 22 May 2009
Since 2000, the number of therapeutic peptides in clinical study has nearly doubled the 1990s rate, due in part to advances ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
